GILBERTO DE LIMA LOPES JUNIOR

Possui graduação em Medicina pela Universidade Federal do Rio Grande do Sul(1997), especialização em MBA pela University of Bradford(2009), residencia-medicapela Hospital de Clínicas de Porto Alegre(1999), residencia-medicapela University of Miami Hospital(2002) e residencia-medicapela University of Miami Hospital(2006). Tem experiência na área de Medicina, com ênfase em Clínica Médica.

Informações coletadas do Lattes em 24/05/2023

Acadêmico

Formação acadêmica

Especialização - Residência médica

2003 - 2006

University of Miami Hospital
Residência médica em: Hematology/Oncology FellowshipNúmero do registro: .

Especialização - Residência médica

1999 - 2002

University of Miami Hospital
Residência médica em: Medicina InternaNúmero do registro: .

Especialização - Residência médica

1998 - 1999

Hospital de Clínicas de Porto Alegre
Residência médica em: Medicina InternaNúmero do registro: .

Especialização em MBA

2009 - 2009

University of Bradford

Graduação em Medicina

1991 - 1997

Universidade Federal do Rio Grande do Sul

Idiomas

Inglês

Compreende Bem, Fala Bem, Lê Bem, Escreve Bem.

Espanhol

Compreende Bem, Fala Bem, Lê Bem, Escreve Bem.

Áreas de atuação

Grande área: Ciências da Saúde / Área: Medicina / Subárea: Clínica Médica.

Grande área: Ciências da Saúde / Área: Medicina / Subárea: Oncologia.

Participação em eventos

Faculty for 2013 World Conference on Lung Cancer.Faculty for 2013 World Conference on Lung Cancer. 2013. (Outra).

Gastrointestinal Cancers Symposium.Cetuximab (C225) in the first-line treatment of advanced colorectal cancer (CRC) patients (Pts) with K-ras wild-type (WT) tumors: Does the choice and schedule of fluoropyrimidine (Fp) matter?. 2012. (Simpósio).

Management of patients with EGFR TKI resistant lung cancer. First International Lung Cancer Symposium.Management of patients with EGFR TKI resistant lung cancer. 2012. (Simpósio).

First-line treatment of non-small cell lung cancer. First International Lung Cancer Symposium.First-line treatment of non-small cell lung cancer. 2012. (Simpósio).

Contemporary management of lung cancer. Malaysian Thoracic Society symposium.Contemporary management of lung cancer. 2012. (Simpósio).

Individualized first line treatment of non-small cell lung cancer: making the most cents . Malaysian Oncological Society symposium.Individualized first line treatment of non-small cell lung cancer: making the most cents . 2012. (Simpósio).

2012 ASCO Annual Meeting.Cost-effectiveness analysis of eribulin (E) versus treatment of physician s choice (TPC) in patients (pts) with pretreated metastatic breast cancer (MBC). 2012. (Encontro).

Presentation and discussion of study on Best of ASCO SE Asia: A randomized, multicenter trial of epirubicin, oxaliplatin, and capecitabine (EOC) with or without panitumumab in previously untreated advanced esophagogastric cancer (REAL3)..103. Presentation and discussion of study on Best of ASCO SE Asia: A randomized, multicenter trial of epirubicin, oxaliplatin, and capecitabine (EOC) with or without panitumumab in previously untreated advanced esophagogastric cancer (REAL3). 2012. (Outra).

Presentation and discussion of study on Best of ASCO SE Asia: Phase III randomized trial of definitive chemoradiotherapy (CRT) with FOLFOX or cisplatin and fluorouracil in esophageal cancer (EC): Final results of the PRODIGE 5/ACCORD 17 trial..102. Presentation and discussion of study on Best of ASCO SE Asia: Phase III randomized trial of definitive chemoradiotherapy (CRT) with FOLFOX or cisplatin and fluorouracil in esophageal cancer (EC): Final results of the PRODIGE 5/ACCORD 17 trial. 2012. (Outra).

Economic indicators, cost-effectiveness and their importance in the practice of oncology. American Society of Clinical Oncology and Brazilian Society of Clinical Oncology (ASCO/SBOC) joint symposium on pharmacoeconomics at the SBOC Congress.Economic indicators, cost-effectiveness and their importance in the practice of oncology. 2011. (Simpósio).

American Society of Clinical Oncology Annual Meeting (ASCO).Gefitinib in the adjuvant treatment of hepatocellular carcinoma: A pilot study by the Singapore hepatocellular carcinoma consortium. 2011. (Encontro).

MAASC Meeting 2011.Cost-effectiveness assessment of aprepitant in the prevention of chemotherapy-induced nausea and vomiting. 2011. (Encontro).

St Gallen Oncology Conference.Cost-benefit analysis of a 21-gene recurrence score for early stage breast cancer in Singapore.. 2011. (Outra).

Asian Oncology Summit. Winner.Nab-paclitaxel (NP) is active in patients with advanced pancreatic cancer (PC) who have progressed on gemcitabine(G)-based therapy. 2011. (Outra).

World Lung Cancer Conference.Comparative Clinical and Cost-Effectiveness Evaluation of Gefitinib and Erlotinib in the Treatment of Advanced Non-Small Cell Lung Cancer. 2011. (Outra).

Moderator: Palliative Care Session. Asian Oncology Summit.Moderator: Palliative Care Session. Asian Oncology Summit. 2011. (Outra).

Moderator, Urologic Cancers Session, Asian Oncology Summit.Moderator, Urologic Cancers Session. 2011. (Outra).

First Singapore Health and Biomedical Congress. Cost effectiveness of EGFR mutation testing and gefitinib. Accepted as oral presentation and recipient of Clinician-Investigator Silver award. 2010. (Congresso).

Gastrointestinal cancer symposium. (ASCO GI).A cost-effectiveness assessment of sorafenib in the treatment of hepatocellular carcinoma in Singapore. 2010. (Simpósio).

4th International Society of Pharmaconomics and Outcomes Research (ISPOR) meeting.Cost-benefit analysis of a 21-gene recurrence score for early stage breast cancer in Singapore. 2010. (Encontro).

Cancer, moderator for oral presentations, International Society for Pharmaco-economics and Outcomes Research Asian Meeting.Cancer, moderator for oral presentations. 2010. (Encontro).

Using genomic profiling to select therapy in early breast cancer in Asia. International Society for Pharmacoeconomics and Outcomes Research Asian Meeting.Using genomic profiling to select therapy in early breast cancer in Asia. 2010. (Encontro).

Gastrointestinal Cancer Symposium (ASCO GI).A multicenter phase II study of neoadjuvant docetaxel and capecitabine in the treatment of gastric cancer in Singapore. 2009. (Simpósio).

12th World Lung Cancer Conference.Gemcitabine and oxaliplatin as second and third line therapy of advanced and metastatic NSCLC: preliminary evidence of activity and improvement in quality of life. 2007. (Outra).

2005 Amgen oncology fellows and pharmacy residents symposium.Free Circulating Deoxyribonucleic Acid (DNA) in Serum as Measured by Real Time Polymerase Chain Reaction (RT-PCR): A New Prognostic and Predictive Factor in Non-Small Cell Lung Cancer?. 2005. (Simpósio).

95th Annual Meeting of the American Association for Cancer Research.Significance of the adhesion molecule CEACAM1 (CD66a) as a prognostic factor for survival in patients with carcinomas of the lung. 2004. (Encontro).

17th International Cancer Congress. Clinical and pharmacokinetic study of etoposide given orally three times daily to patients with AIDS-related Kaposi s sarcoma (AIDS-KS)h. 1998. (Congresso).

87th Annual Meeting of the American Association for Cancer Research..Inhibition of protein kinase C (PKC) activity by tamoxifen in cultured gliomas cells. 1996. (Encontro).

86th Annual Meeting. American Association for Cancer Research.dose Tamoxifen interferes with Etoposide disposition in the cerebrospinal fluid of gliomas patients and p-glycoprotein-expressing tissues in rats. 1995. (Encontro).

VI Scientific Initiation Meeting at Federal University of Rio Grande do Sul.Altered disposition of etoposide (VP-16) by tamoxifen (TMX) in p-glycoprotein (p-gp)- containing tissues in rats. 1994. (Encontro).

Produções bibliográficas

HOSEIN, PETER J. ; DE LIMA LOPES, GILBERTO ; PASTORINI, VITOR H. ; GOMEZ, CHRISTINA ; MACINTYRE, JESSICA ; ZAYAS, GLORIA ; REIS, ISILDINHA ; MONTERO, ALBERTO J. ; MERCHAN, JAIME R. ; ROCHA LIMA, CAIO M. . A Phase II Trial of nab-Paclitaxel as Second-line Therapy in Patients With Advanced Pancreatic Cancer. American Journal of Clinical Oncology , v. 36, p. 151-156, 2013.
LOPES, GILBERTO ; GLÜCK, STEFAN ; AVANCHA, KIRAN ; MONTERO, ALBERTO J. . A cost effectiveness study of eribulin versus standard single-agent cytotoxic chemotherapy for women with previously treated metastatic breast cancer. Breast Cancer Research and Treatment , v. 137, p. 187-193, 2013.
DE LIMA LOPES, GILBERTO ; CHIEN, REBECCA ; HORNBERGER, JOHN . Cost-benefit of the 21-gene Breast Cancer Recurrence Score Assay for Patients in Singapore. The Breast Journal , v. 19, p. 220-221, 2013.
SOON, SWEE-SUNG ; LIM, HWEE-YONG ; LOPES, GILBERTO ; AHN, JEONGHOON ; HU, MIN ; IBRAHIM, HISHAMSHAH MOHD ; JHA, ANAND ; KO, BOR-SHENG ; LEE, PAK WAI ; MACDONELL, DIANA ; SIRACHAINAN, EKAPHOP ; WEE, HWEE-LIN . Roles of Cancer Registries in Enhancing Oncology Drug Access in the Asia-Pacific Region. Asian Pacific Journal of Cancer Prevention , v. 14, p. 2159-2165, 2013.
CRUZ, MARCELO R. S. ; DE LIMA LOPES, GILBERTO . Colon Cancer Liver Metastasis: Addition of Antiangiogenesis or EGFR Inhibitors to Chemotherapy. Current Colorectal Cancer Reports , v. 9, p. 68-73, 2013.
GOSS, PAUL E LEE, BRITTANY L BADOVINAC-CRNJEVIC, TANJA STRASSER-WEIPPL, KATHRIN CHAVARRI-GUERRA, YANIN LOUIS, JESSICA ST VILLARREAL-GARZA, CYNTHIA UNGER-SALDAÑA, KARLA FERREYRA, MAYRA DEBIASI, MÁRCIO LIEDKE, PEDRO ER TOUYA, DIEGO WERUTSKY, GUSTAVO HIGGINS, MICHAELA FAN, LEI VASCONCELOS, CLAUDIA CAZAP, EDUARDO VALLEJOS, CARLOS MOHAR, ALEJANDRO KNAUL, FELICIA ARREOLA, HECTOR BATURA, REKHA LUCIANI, SILVANA SULLIVAN, RICHARD FINKELSTEIN, DIANNE , et al. SIMON, SERGIO BARRIOS, CARLOS KIGHTLINGER, REBECCA GELRUD, ANDRES BYCHKOVSKY, VLADIMIR LOPES, GILBERTO STEFANI, STEPHEN BLAYA, MARCELO SOUZA, FABIANO HAHN SANTOS, FRANKLIN SANTANA KAEMMERER, ALBERTO DE AZAMBUJA, EVANDRO ZORILLA, ANDRES FELIPE CARDONA MURILLO, RAUL JERONIMO, JOSE TSU, VIVIEN CARVALHO, ANDRE GIL, CARLOS FERREIRA STERNBERG, CINTHYA DUEÑAS-GONZALEZ, ALFONSO SGROI, DENNIS CUELLO, MAURICIO FRESCO, RODRIGO REIS, RUI MANUEL MASERA, GUISEPPE GABÚS, RAÚL RIBEIRO, RAUL KNUST, RENATA ISMAEL, GUSTAVO ROSENBLATT, EDUARDO ROTH, BERTA VILLA, LUISA SOLARES, ARGELIA LARA LEON, MARTA XIMENA TORRES-VIGIL, ISABEL COVARRUBIAS-GOMEZ, ALFREDO HERNÁNDEZ, ANDRÉS BERTOLINO, MARIELA SCHWARTSMANN, GILBERTO SANTILLANA, SERGIO ESTEVA, FRANCISCO FEIN, LUIS MANO, MAX GOMEZ, HENRY HURLBERT, MARC DURSTINE, ALESSANDRA AZENHA, GUSTAVO ; Planning cancer control in Latin America and the Caribbean. Lancet Oncology , v. 14, p. 391-436, 2013.
LOPES, GILBERTO DE LIMA ; DE SOUZA, JONAS A. ; BARRIOS, CARLOS . Access to cancer medications in low- and middle-income countries. NAT REV CLIN ONCOL , v. 10, p. 314-322, 2013.
DE SOUZA, JONAS A. ; LOPES, GILBERTO DE LIMA ; COHEN, EZRA E.W. . Pharmacoeconomic issues in head and neck oncology. Current Opinion in Oncology , v. 25, p. 1-217, 2013.
MERCHAN, JAIME R. ; FERRELL, ANNAPORNA ; MACINTYRE, JESSICA ; CIOMBOR, KRISTEN K. ; LEVI, JOE ; RIBEIRO, AFONSO ; SLEEMAN, DANNY ; FLORES, AUREA ; LOPES, GILBERTO ; ROCHA-LIMA, CAIO M. . Phase II Study of Gemcitabine, Oxaliplatin, and Cetuximab in Advanced Pancreatic Cancer. American Journal of Clinical Oncology , v. 35, p. 446-450, 2012.
DE LIMA LOPES, GILBERTO ; SEGEL, JOEL E. ; TAN, DANIEL S. W. ; DO, YOUNG K. ; MOK, TONY ; FINKELSTEIN, ERIC A. . Cost-effectiveness of epidermal growth factor receptor mutation testing and first-line treatment with gefitinib for patients with advanced adenocarcinoma of the lung. Cancer (Print) , v. 118, p. 1032-1039, 2012.
MONTERO, ALBERTO J. ; AVANCHA, KIRAN ; GLÜCK, STEFAN ; LOPES, GILBERTO . A cost-benefit analysis of bevacizumab in combination with paclitaxel in the first-line treatment of patients with metastatic breast cancer. Breast Cancer Research and Treatment , v. 132, p. 747-751, 2012.
KU, GEOFFREY Y. ; HAALAND, BENJAMIN A. ; LIMA LOPES, GILBERTO . Cetuximab in the first-line treatment of K-ras wild-type metastatic colorectal cancer: the choice and schedule of fluoropyrimidine matters. Cancer Chemotherapy and Pharmacology , v. 70, p. 231-238, 2012.
PARKER, JAYSON L. ; LUSHINA, NADIA ; BAL, PRABJOT S. ; PETRELLA, TERESA ; DENT, REBECCA ; LOPES, GILBERTO . Impact of biomarkers on clinical trial risk in breast cancer. Breast Cancer Research and Treatment , v. 136, p. 179-185, 2012.
MONTERO, ALBERTO J. ; ESCOBAR, MAURICIO ; LOPES, GILBERTO ; GLÜCK, STEFAN ; VOGEL, CHARLES . Bevacizumab in the Treatment of Metastatic Breast Cancer: Friend or Foe?. CURR ONCOL REP , v. 14, p. 1-11, 2012.
DE SOUZA, J. A. ; DE LIMA LOPES, G. . What Patients and Providers Should Understand About Economic Evaluations in Oncology. Journal of Oncology Practice , v. 8, p. 231-232, 2012.
KU, GEOFFREY ; TAN, IAIN BEEHUAT ; YAU, THOMAS ; BOKU, NARIKAZU ; LAOHAVINIJ, SUDSAWAT ; CHENG, ANN-LII ; KANG, YOON-KOO ; DE LIMA LOPES, GILBERTO . Management of colon cancer: resource-stratified guidelines from the Asian Oncology Summit 2012. Lancet Oncology , v. 13, p. e470-e481, 2012.
KU, GEOFFREY Y ; DE LIMA LOPES JR, GILBERTO ; CHANG, ALEX Y . Bevacizumab in combination with oxaliplatin and doxorubicin or liposomal doxorubicin for hepatocellular cancer: A case series. ASIA-PAC J CLIN ONCO , v. 7, p. 174-179, 2011.
LIMA LOPES, GILBERTO ; DICKSEY, JENNIFER S. ; PETERS, WILLIAM P. ; PALALAY, MELVIN ; CHANG, ALEX Y. . Final results of a prematurely discontinued Phase 1/2 study of eniluracil with escalating doses of 5-fluorouracil administered orally in patients with advanced hepatocellular carcinoma. Cancer Chemotherapy and Pharmacology , v. 68, p. 1067-1073, 2011.
LOPES JR., GILBERTO DE LIMA ; J, Kukuschtca ; P, Portillo . Pemetrexed in Asian patients: Experience at the Johns Hopkins Singapore International Medical Centre. SINGAP MED J , v. 52, p. 190, 2011.
DE LIMA LOPES, GILBERTO . Societal Costs and Benefits of Treatment with Trastuzumab in Patients with Early HER2neu-Overexpressing Breast Cancer in Singapore. BMC Cancer (Online) , v. 11, p. 178, 2011.
KU, GEOFFREY Y. ; HAALAND, BENJAMIN A. ; DE LIMA LOPES, GILBERTO . Gefitinib vs. chemotherapy as first-line therapy in advanced non-small cell lung cancer: Meta-analysis of phase III trials. Lung Cancer , v. 74, p. 469-473, 2011.
DE SOUZA, J. A. ; DE LIMA LOPES, G. . Medicare Reimbursement Changes and the Practice of Oncology: Understanding of the Past Is a Key to the Future. Journal of Oncology Practice , v. 7, p. 306-308, 2011.
KU, GEOFFREY Y ; LIMA JOPES JR, GILBERTO DE . EML4-ALK in non-small-cell lung cancer: the breathtaking progress from benchtop to Phase III clinical trial. Therapy , v. 8, p. 55-61, 2011.
Lopes, G. ; DENT, R. . Weighed, Measured, and Still Searching: Bevacizumab in the Treatment of Unselected Patients with Advanced Breast Cancer. The Oncologist (Dayton, Ohio) , v. 16, p. 1669-1671, 2011.
BASTOS, BRUNO R. ; HATOUM, GEORGES F. ; WALKER, GAIL R. ; TOLBA, KHALED ; TAKITA, CHRISTIANE ; GOMEZ, JORGE ; SANTOS, EDGARDO S. ; LOPES, GILBERTO ; RAEZ, LUIS E. . Efficacy and Toxicity of Chemoradiotherapy with Carboplatin and Irinotecan Followed by Consolidation Docetaxel for Unresectable Stage III Non-small Cell Lung Cancer. Journal of Thoracic Oncology , v. 5, p. 533-539, 2010.
LOBO, CHRISTOPHER ; LOPES, GILBERTO ; BAEZ, ODALYS ; CASTRELLON, AURELIO ; FERRELL, ANNAPOORNA ; HIGGINS, CONNIE ; HURLEY, ERIN ; HURLEY, JUDITH ; REIS, ISILDINHA ; RICHMAN, STEPHEN ; SEO, PEARL ; SILVA, ORLANDO ; SLINGERLAND, JOYCE ; TUKIA, KELENI ; WELSH, CATHERINE ; GLÜCK, STEFAN . Final results of a phase II study of nab-paclitaxel, bevacizumab, and gemcitabine as first-line therapy for patients with HER2-negative metastatic breast cancer. Breast Cancer Research and Treatment , v. 123, p. 427-435, 2010.
KU, GEOFFREY Y. ; CHOPRA, AKHIL ; LOPES, GILBERTO DE LIMA . Successful treatment of two lung cancer patients with erlotinib following gefitinib-induced hepatotoxicity. Lung Cancer , v. 70, p. 223-225, 2010.
TAN, KER KAN ; LOPES JR., GILBERTO DE LIMA ; SIM, RICHARD . How Uncommon are Isolated Lung Metastases in Colorectal Cancer? A Review from Database of 754 Patients Over 4 Years. Journal of Gastrointestinal Surgery , v. 13, p. 642-648, 2009.
Lopes, G. . Rewarding Innovation In Drug Discovery. Health Affairs (Millwood, Va.) , v. 28, p. 922-923, 2009.
DE LIMA LOPES, GILBERTO . 'Fin de siècle'--how we got into this financial and economic crisis and what implications it has for the practice of medicine in Singapore. SINGAP MED J , v. 50, p. 648-651, 2009.
DE LIMA LOPES, GILBERTO . Perspectives in Lung Cancer--Third Asian-pacific Conference. 11-12 September 2009, Bangkok, Thailand. IDrugs (London) , v. 12, p. 689-691, 2009.
SILVA, ORLANDO ; LOPES, GILBERTO ; MORGENZSTERN, DANIEL ; LOBO, CHRISTOPHER ; DOLINY, PHILOMENA ; SANTOS, EDGARDO ; ABDULLAH, SAKHER ; GAUTAM, UMANG ; REIS, ISILDINHA ; WELSH, CATHERINE ; SLINGERLAND, JOYCE ; HURLEY, JUDITH ; GLUCK, STEFAN . A Phase II Trial of Split, Low-Dose Docetaxel and Low-Dose Capecitabine: A Tolerable and Efficacious Regimen in the First-Line Treatment of Patients with HER2/neu-Negative Metastatic Breast Cancer. Clinical Breast Cancer , v. 8, p. 162-167, 2008.
DE LIMA LOPES, G. ; GLUCK, S. . Health Economics in the Journal of Clinical Oncology and an Evaluation of the Indirect Costs and Benefits Associated With Adjuvant Trastuzumab. Journal of Clinical Oncology , v. 25, p. 3382-3383, 2007.
DE LIMA LOPES, GILBERTO ; CHIAPPORI, ALBERTO ; SIMON, GEORGE ; HAURA, ERIC ; SULLIVAN, DAN ; ANTONIA, SCOTT ; LANGEVIN, MICHEL ; LUSH, RICHARD ; ROCHA-LIMA, CAIO MAX . Phase I study of carboplatin in combination with gemcitabine and irinotecan in patients with solid tumors. Cancer (Print) , v. 109, p. 1413-1419, 2007.
LOBO, CHRISTOPHER ; LOPES, GILBERTO ; SILVA, ORLANDO ; GLUCK, STEFAN . Paclitaxel albumin-bound particles (abraxane-) in combination with bevacizumab with or without gemcitabine: Early experience at the University of Miami/Braman Family Breast Cancer Institute. Biomedicine & Pharmacotherapy , v. 61, p. 531-533, 2007.
CHANG, ALEX Y. ; LOPES, GILBERTO ; HSIN, KOO WEN ; LIM, ROBERT ; FONG, FOO KIAN ; WONG, JOHN . Phase II Trial of 5-Fluorouracil/Leucovorin/Gemcitabine/Cisplatin as Second-Line Treatment in Patients with Metastatic or Recurrent Colorectal Carcinoma: A Cancer Therapeutics Research Group Study. Clinical Colorectal Cancer , v. 6, p. 646-651, 2007.
LOPES, GILBERTO ; QUESADA, JOSE ; AHN, EUGENE ; FLORES, AUREA ; RIBEIRO, AFONSO ; ROCHA-LIMA, CAIO MAX . Oxaliplatin and Fixed-Rate Infusional Gemcitabine in the Second-Line Treatment of Patients with Metastatic Colon Cancer: Final Results of a Phase II Trial Prematurely Closed as a Result of Poor Accrual. Clinical Colorectal Cancer , v. 6, p. 641-645, 2007.
DE LIMA LOPES, GILBERTO ; ROCHA LIMA, CAIO MAX . Emphysematous Cholecystitis in a Patient with Gastrointestinal Stromal Tumor Treated with Sunitinib. Pharmacotherapy (Carlisle, MA.) , v. 27, p. 775-777, 2007.
RAEZ, LUIS E. ; SANTOS, EDGARDO S. ; LOPES, GILBERTO ; ROSADO, MANUEL F. ; NEGRET, LAWRENCE M. ; ROCHA-LIMA, CAIO ; TOLBA, KALHED ; FARFAN, NANCY ; HAMILTON-NELSON, KARA ; SILVA, ORLANDO ; ROMAN, ELOY . Efficacy and safety of oxaliplatin and docetaxel in patients with locally advanced and metastatic non-small-cell lung cancer (NSCLC). Lung Cancer , v. 53, p. 347-353, 2006.
GARCIA, SANTIAGO ; CANONIERO, MARIANA ; LOPES, GILBERTO ; SORIANO, ANDRÉS OMAR . Metamizole Use Among Hispanics in Miami: Report of a Survey Conducted in a Primary Care Setting. Southern Medical Journal (Birmingham, Ala. Print) , v. 99, p. 924-926, 2006.
LOPES, GILBERTO ; VINCEK, VLADIMIR ; RAEZ, LUIS E. . Pemetrexed-associated urticarial vasculitis. Lung Cancer , v. 51, p. 247-249, 2006.
LOPES, GILBERTO ; DECESARE, TERESA ; GHURANI, GISELLE ; VINCEK, VLADIMIR ; JORDA, MERCE ; GLÜCK, STEFAN ; SILVA, ORLANDO . Primary Ectopic Breast Cancer Presenting as a Vulvar Mass. Clinical Breast Cancer , v. 7, p. 278-279, 2006.
GARCIA, SANTIAGO ; CANIONERO, MARIANA ; LOPES, GILBERTO . Dipyrone-Induced Granulocytopenia: A Case for Awareness. Pharmacotherapy (Carlisle, MA.) , v. 26, p. 440-442, 2006.
LOPES, GILBERTO ; ROCHA LIMA, CAIO MAX S. . Docetaxel in the Management of Advanced Pancreatic Cancer. Seminars in Oncology , v. 32, p. 10-23, 2005.
Escalon, M. ; DE LIMA LOPES, GILBERTO . T-cell non-Hodgkin s lymphoma: prognostic factors and treatment. The American Journal of Oncology Review , v. 4, p. 766-769, 2005.
CHIRINOS, JULIO A ; TAMARIZ, LEONARDO J. ; LOPES, GILBERTO ; DEL CARPIO, FREDDY ; ZHANG, XIAOHONG ; MILIKOWSKI, CLARA ; LICHTSTEIN, DANIEL M. . Large vessel involvement in ANCA-associated vasculitides: report of a case and review of the literature. Clinical Rheumatology (Printed) , v. 23, p. 152-159, 2004.
Lopes G ; Gerchman, F. ; Bolognesi, G. ; Osorio, M.V.S. ; Bisol, T. ; Von Eye, G. . Hipertricose Ciliar Adquirida em SIDA, Uma Revisao. [Hypertricosis of the Eyelashes in AIDS: A Review]. Revista HCPA (UFRGS. Impresso) , v. 16, p. 25-27, 1996.
Gerchman, F. ; LOPES JUNIOR, G. L. ; Bolognesi, G. ; Ferreira, J. ; Bisol, T. . Hipertricose Ciliar como sinal semiologico da Sindrome da Imunodeficiencia Adquirida. [Hypertricosis of the Eyelashes as a semiologic sign of AIDS]. Revista AMRIGS , v. 39, p. 246, 1995.
DE LIMA LOPES JR, GILBERTO . Diagnostic procedures. In: Silva O, Raez L. (Org.). Lung cancer: a practical guide. 1ed.: Elsevier, 2008, v. , p. 1-.
DE LIMA LOPES JR, GILBERTO ; Raez, L . Adjuvant chemotherapy in non-small cell lung cancer. In: Silva O, Raez L. (Org.). Lung cancer: a practical guide. 1ed.: Elsevier, 2008, v. , p. 3-.
DE LIMA LOPES JR, GILBERTO ; ROCHA LIMA, CAIO M. . Cancer de Pancreas. In: Guimaraes J. (Org.). Rotinas em Oncologia. 1ed.: Artes Médicas, 2008, v. , p. 1-.
DE LIMA LOPES JR, GILBERTO ; SILVA, ORLANDO . Investigational Agents. In: Silva O, Zurrida S. (Org.). Breast cancer: a practical guide. 1ed.: Elsevier, 2005, v. , p. 1-.
DE LIMA LOPES JR, GILBERTO ; SILVA, ORLANDO ; GLUCK, S. . Adjuvant Hormonal Therapy. In: Silva O, Zurrida S. (Org.). Breast cancer: a practical guide. 1ed.: Elsevier, 2005, v. , p. 3-.
DE LIMA LOPES JR, GILBERTO ; SILVA, ORLANDO . Benign breast disease. In: Silva O, Zurrida S. (Org.). Breast cancer: a practical guide. 1ed.: Elsevier, 2005, v. , p. 5-.
DE LIMA LOPES JR, GILBERTO ; Sprinz, E . Infecções por Herpes Vírus: Simples, Varicela-Zoster, Epstein-Barr, HSV-8. In: Sprinz E, Finkelsztejn A Sprinz E, Finkelsztejn A. (Org.). Rotinas em HIV e AIDS. 1ed.: , 1999, v. , p. 1-.
MONTERO, ALBERTO J. ; AVANCHA, KIRAN ; GLUCK, S. ; DE LIMA LOPES, GILBERTO . Cost-effectiveness analysis of eribulin (E) versus treatment of physician s choice (TPC) in patients (pts) with pretreated metastatic breast cancer (MBC). In: 2012 ASCO Annual Meeting, 2012, Chicago. J Clin Oncol, 2012. v. 30. p. e16525.
Chopra, A. ; MONTERO, ALBERTO J. ; AVANCHA, KIRAN ; GLUCK, S. ; DE LIMA LOPES, GILBERTO . Cost-effectiveness evaluation of abiraterone in the treatment of patients with castration-resistant prostate cancer who previously received docetaxel. In: 2012 ASCO Annual Meeting, 2012, Chicago. J Clin Oncol, 2012. v. 30. p. e15107.
HAALAND, BENJAMIN A. ; Chopra, A. ; DE LIMA LOPES, GILBERTO . Comparative effectiveness of front-line agents in the treatment of metastatic clear cell renal cell carcinoma. In: 2012 ASCO Annual Meeting, 2012. J Clin Oncol, 2012. v. 30. p. e15045.
Falconi, A. ; DE LIMA LOPES, GILBERTO ; PARKER, JAYSON L. . Clinical trial risk reduction in non-small cell lung cancer though the use of biomarkers and receptor-targeted therapies. In: 2012 ASCO Annual Meeting, 2012. J Clin Oncol, 2012. v. 31. p. 8040.
Zeichner, S.B. ; AVANCHA, KIRAN ; DE LIMA LOPES, GILBERTO ; GLUCK, S. ; MONTERO, ALBERTO J. . Cost-effectiveness of everolimus plus exemestane in post-menopausal hormone receptor positive metastatic breast cancer. In: 2012 ASCO Annual Meeting, 2012. J Clin Oncol, 2012. v. 31. p. 6548.
DE LIMA LOPES, GILBERTO ; CHIEN, REBECCA ; Skrzypczak, S. . Cost-benefit analysis of a 21-gene recurrence score for early stage breast cancer in Singapore.. In: St Gallen Oncology Conference, 2011, St. Gallen. Abstract Book, 2011. p. P215A.
SANTOS, EDGARDO ; Behshid, K ; Zelnick, L ; DE LIMA LOPES, GILBERTO ; Jorda, M ; Bejarano, P ; Raez, L . Significance of the adhesion molecule CEACAM1 (CD66a) as a prognostic factor for survival in patients with carcinomas of the lung. In: 95th Annual Meeting of the American Association for Cancer Research, 2004, Orlando. Abstract Book, 2004.
Schwartsmann, G ; Sprinz, E ; Stefani, S ; Leone, L ; Loitzenbauer, B ; Bortolini, M ; Kronfeld, M ; DE LIMA LOPES, GILBERTO ; Sander, E ; Mans, D . Clinical and pharmacokinetic study of etoposide given orally three times daily to patients with AIDS-related Kaposi s sarcoma (AIDS-KS). In: 17th International Cancer Congress, 1998, Rio de Janeiro. Proceedings American Society Clinical Oncology, 1998. v. 17. p. 966.
Brondani, A ; Mans, DRA ; Bernard, EA ; DE LIMA LOPES, GILBERTO ; Schwartsmann, G . Inhibition of protein kinase C (PKC) activity by tamoxifen in cultured gliomas cells. In: 87th Annual Meeting of the American Association for Cancer Research., 1996. Abstract Book, 1996. v. 1. p. 2889.
Mans, DRA ; Malcon, C ; DE LIMA LOPES JR, GILBERTO . dose Tamoxifen interferes with Etoposide disposition in the cerebrospinal fluid of gliomas patients and p-glycoprotein-expressing tissues in rats. In: VI Scientific Initiation Meeting at Federal University of Rio Grande do Sul, 1994, Toronto. Abstract Book, 1994. v. 1. p. 1755-1755.
KU, GEOFFREY Y ; HAALAND, BENJAMIN A. ; DE LIMA LOPES, GILBERTO . Cetuximab (C225) in the first-line treatment of advanced colorectal cancer (CRC) patients (Pts) with K-ras wild-type (WT) tumors: Does the choice and schedule of fluoropyrimidine (Fp) matter?. 2012. (Apresentação de Trabalho/Simpósio).
KU, GEOFFREY Y ; HAALAND, BENJAMIN A. ; DE LIMA LOPES, GILBERTO . Meta-analysis of randomized phase II and phase III trials of gemcitabine with/without S-1 in Asian patients with advanced pancreatic cancer. 2012. (Apresentação de Trabalho/Simpósio).
DE LIMA LOPES, GILBERTO ; Liau, K. ; Ho, C. . Gefitinib in the adjuvant treatment of hepatocellular carcinoma: A pilot study by the Singapore hepatocellular carcinoma consortium. 2011. (Apresentação de Trabalho/Outra).
DE LIMA LOPES, GILBERTO ; FINKELSTEIN, ERIC A. ; DO, YOUNG K. . Cost effectiveness of EGFR mutation testing and gefitinib. Accepted as oral presentation and recipient of Clinician-Investigator Silver award. 2011. (Apresentação de Trabalho/Outra).
DE LIMA LOPES, GILBERTO ; HOSEIN, PETER J. ; ROCHA-LIMA, CAIO . Nab-paclitaxel (NP) is active in patients with advanced pancreatic cancer (PC) who have progressed on gemcitabine(G)-based therapy. 2011. (Apresentação de Trabalho/Outra).
DE LIMA LOPES, GILBERTO ; Zhang, S. ; CHANG, ALEX Y . Cost-effectiveness assessment of aprepitant in the prevention of chemotherapy-induced nausea and vomiting. 2011. (Apresentação de Trabalho/Outra).
MONTERO, ALBERTO J. ; GLUCK, S. ; DE LIMA LOPES, GILBERTO . Cost-effectiveness of bevacizumab in the treatment of advanced breast cancer. 2011. (Apresentação de Trabalho/Outra).
DE LIMA LOPES, GILBERTO ; SEGEL, JOEL E. ; Tan, D. ; DO, YOUNG K. ; MOK, TONY ; FINKELSTEIN, ERIC A. . Comparative Clinical and Cost-Effectiveness Evaluation of Gefitinib and Erlotinib in the Treatment of Advanced Non-Small Cell Lung Cancer. 2011. (Apresentação de Trabalho/Conferência ou palestra).
DE LIMA LOPES, GILBERTO ; SEGEL, JOEL E. ; Tan, D. ; DO, YOUNG K. ; Novello, S. ; Scagliotti, G. ; MOK, TONY ; FINKELSTEIN, ERIC A. . Epidermal Growth Factor Receptor (EGFR) Mutation Testing and First Line Treatment with Gefitinib is a Dominant Strategy in the Treatment of Asian and European Patients with Advanced Non-Small Lung Cancer (NSCLC). 2011. (Apresentação de Trabalho/Conferência ou palestra).
DE LIMA LOPES, GILBERTO ; FINKELSTEIN, ERIC A. ; DO, YOUNG K. . Cost effectiveness of EGFR mutation testing and gefitinib. Accepted as oral presentation and recipient of Clinician-Investigator Silver award. 2010. (Apresentação de Trabalho/Outra).
DE LIMA LOPES, GILBERTO ; CHIEN, REBECCA ; HORNBERGER, JOHN . Cost benefit analysis of a 21-gene recurrence score in Singapore. Accepted as oral presentation and winner of the Young Investigator award, Health Outcomes Research category.. 2010. (Apresentação de Trabalho/Congresso).
DE LIMA LOPES, GILBERTO ; Soh. J. ; Wong, W. ; Tan, D. ; Lim, K. ; FONG, FOO KIAN ; Poon, D. ; Ong, S. ; Mesenas, S. ; CHANG, ALEX Y ; Singapore Gastric Cancer Consortium . A multicenter phase II study of neoadjuvant docetaxel and capecitabine in the treatment of gastric cancer in Singapore. 2009. (Apresentação de Trabalho/Simpósio).
DE LIMA LOPES, GILBERTO ; Ho, C. ; Liau, K. ; Chung, A. ; Cheow, P. ; CHANG, ALEX Y ; Singapore Gastric Cancer Consortium . Adjuvant gefitinib in hepatocellular carcinoma (HCC): An ongoing pilot study by the Singapore Hepatocellular Carcinoma Consortium. 2009. (Apresentação de Trabalho/Simpósio).
DE LIMA LOPES, GILBERTO ; Alencar, A. ; Blaya, M. . Gemcitabine and oxaliplatin as second and third line therapy of advanced and metastatic NSCLC: preliminary evidence of activity and improvement in quality of life. 2007. (Apresentação de Trabalho/Comunicação).

Outras produções

DE LIMA LOPES, GILBERTO . Invited Reviewer for American Journal of Public Health. 2013.

DE LIMA LOPES, GILBERTO . Member of the Editorial Board for South Asian Journal of Cancer. 2013.

DE LIMA LOPES, GILBERTO . Invited Reviewer for Cancer Control: Journal of the Moffitt Cancer Center. 2012.

DE LIMA LOPES, GILBERTO . Invited Reviewer for Breast Cancer: Targets and Therapy. 2012.

DE LIMA LOPES, GILBERTO . Invited Reviewer for Health and Quality of Life Outcomes. 2012.

DE LIMA LOPES, GILBERTO . Member of the Editorial Board for The Journal of Market Access and Health Policy. 2012.

DE LIMA LOPES, GILBERTO . Invited Reviewer for Lung Cancer. 2011.

DE LIMA LOPES, GILBERTO . Invited Reviewer for Journal of Oncology Practice, 2011 (8 reviews). 2011.

DE LIMA LOPES, GILBERTO . Invited Reviewer for Onkologie. 2011.

DE LIMA LOPES, GILBERTO . Invited Reviewer for British Journal of Cancer. 2011.

DE LIMA LOPES, GILBERTO . Invited Reviewer for the Journal of Graduate Medical Education. 2010.

DE LIMA LOPES, GILBERTO . Invited Reviewer for the BMC Cancer. 2010.

DE LIMA LOPES, GILBERTO . Invited Reviewer for Value in Health and Value in Health Regional Issues, since 2010 (7 reviews). 2010.

DE LIMA LOPES, GILBERTO . Invited Reviewer for Singapore Medical Journal, since 2010 (4 reviews). 2010.

DE LIMA LOPES, GILBERTO . Member of the Editorial Board for The Journal of Thoracic Diseases. 2010.

DE LIMA LOPES, GILBERTO . Invited Reviewer for Clinical Breast Cancer. 2009.

DE LIMA LOPES, GILBERTO . Member of the Editorial Board for The World Journal of Gastrointestinal Surgery. 2009.

DE LIMA LOPES, GILBERTO . Invited Reviewer for Journal of Thoracic Oncology, since 2008, 9 reviews. 2008.

DE LIMA LOPES, GILBERTO . Invited Reviewer for Archives of Gynecology and Obstetrics. 2008.

DE LIMA LOPES, GILBERTO . Member of the Editorial Board for The Open Colorectal Cancer Journal. 2008.

DE LIMA LOPES, GILBERTO . Invited Reviewer, ASCO SEP: Medical Oncology Self Evaluation Program, 2007. 2007.

DE LIMA LOPES, GILBERTO . Invited Reviewer for journal Cancer, since 2007, 3 reviews. 2007.

DE LIMA LOPES, GILBERTO . Invited Reviewer for journal Clinical Medicine: Oncology, 2007. 2007.

DE LIMA LOPES, GILBERTO . Invited Reviewer for Cancer Chemotherapy and Pharmacology, since 2007, 2 reviews. 2007.

DE LIMA LOPES, GILBERTO . Invited Reviewer for Cancer Informatics. 2007.

DE LIMA LOPES, GILBERTO . Invited Reviewer for journal Pharmacotherapy, since 2006, 2 reviews. 2006.

DE LIMA LOPES, GILBERTO . Invited Reviewer for Asia Pacific Journal of Clinical Oncology, since 2006, 9 reviews. 2006.

DE LIMA LOPES, GILBERTO . Invited Reviewer for journal The Breast, since 2005, 8 reviews. 2005.

Histórico profissional

Endereço profissional

Johns Hopkins University. , 11 Jalan Tan Tock Seng, Level 1, 308433 - Singapore, - Cingapura, Telefone: (65) 9621816